Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Whole Exome Sequencing Companies

Whole exome sequencing (WES) is a high-throughput genomic technique that sequences the exons, or coding regions, of an individual's genome. This approach is valuable for identifying genetic variations associated with various diseases and conditions. Many companies offer WES services for both research and clinical applications.

Whole exomeWhole Exome Sequencing Key Companies

*Disclaimer: List of key companies in no particular orderLatest Whole exome sequencing Companies Update

Sep 2023: In Genome Valley in Hyderabad, Eurofins, a Belgian testing solutions supplier for industries including environment, agrisciences, and life sciences, has launched what is expected to grow to be its largest biopharma services facility in India. The campus, being developed on a 15-acre plot of land, began with a built-up lab area of 1 lakh square feet, but it is anticipated to grow 10X to become a 1 million square foot institution. Global pharmaceutical businesses will receive services from the Eurofins Genome Valley campus in safety toxicology, formulation development, bioanalytical services, and discovery chemistry and biology.

Oct 2023: EU antitrust regulators have forced U.S. genetic testing business Illumina to sell cancer test manufacturer Grail after the company closed the purchase before receiving their consent. Fearing that some of these agreements may hinder innovation and diminish competition in the industry, antitrust monitors on both sides of the Atlantic have increased their scrutiny of pharmaceutical and biotech deals in recent years. The EU fined Illumina a record 432 million euros ($457 million) for antitrust violations related to gun-jumping. The $7.1 billion purchase was then banned by the EU competition regulator in 2022 because of worries that Illumina would be motivated to prevent Grail's competitors from using its technology to create their blood-based cancer identification tools.

List of Whole exome sequencing Key companies in the market

Illumina Inc. (US)

BGI (China)

Eurofins Scientific (Belgium)

Thermo Fisher Scientific (US)

Agilent Technologies Inc. (US)

Hoffmann-La Roche Ltd. (Switzerland)

GENEWIZ (US)

Ambry Genetics (US)

Macrogen Inc. (South Korea)

Integragen SA (France)

Whole Exome Sequencing Market Highlights:

Whole Exome Sequencing Market Size

Whole Exome Sequencing Market Trends

Whole Exome Sequencing Market Analysis

Whole Exome Sequencing Market Share

Whole Exome Sequencing Market Highlights:

Whole Exome Sequencing Market Trends

Whole Exome Sequencing Market Analysis

Whole Exome Sequencing Market Share

Whole Exome Sequencing Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.